Deakin University, IMPACT - the Institute for Mental and Physical Health and Clinical Translation, Food & Mood Centre, School of Medicine, Barwon Health, Geelong, Victoria, Australia.
Boden Collaboration for Obesity, Nutrition, Exercise and Eating Disorders, University of Sydney, Sydney, New South Wales, Australia.
Int J Eat Disord. 2021 Jun;54(6):936-951. doi: 10.1002/eat.23469. Epub 2021 Feb 2.
Gastrointestinal (GI) disturbances are a frequent and burdensome experience for patients with anorexia nervosa (AN). How GI symptoms respond to current interventions is not well characterized, yet is critical to facilitate treatment success, and to inform the development of new treatments for AN. Therefore, the aim of this systematic review was to identify which treatments are effective in improving GI symptoms in patients with AN.
A systematic search for studies of AN treatments measuring GI symptoms pre- and post-treatment was conducted in May 2020 (PROSPERO ID: CRD42020181328). After removal of duplicates, title and abstracts of 3,370 studies were screened. Methodological quality was assessed using National Institute of Health Quality Assessment Tool.
Following full-text screening, 13 studies (12 observational studies and 1 randomized double-blind placebo-controlled trial) with 401 participants met eligibility criteria and were included. All observational studies included a component of nutritional rehabilitation, with half (n = 6) involving concurrent psychological treatment. The randomized controlled trial reported a drug therapy. Eleven studies reported an improvement in all (n = 6) or at least one (n = 5) patient-reported GI symptom following treatment. Two studies reported no change. Methodological quality was fair or poor across all studies.
This is the first systematic review to synthesize available evidence on the trajectory of patient-reported GI symptoms from commencement to end of treatment for AN. The results suggest that most studies showed improvement in one or more GI symptom in response to current treatments. Future therapeutic approaches should consider GI symptoms within their design for optimal treatment adherence and outcomes.
胃肠道(GI)紊乱是厌食症(AN)患者常见且负担沉重的体验。目前干预措施对 GI 症状的反应如何尚不清楚,但这对于促进治疗成功以及为 AN 开发新的治疗方法至关重要。因此,本系统评价的目的是确定哪些治疗方法可有效改善 AN 患者的 GI 症状。
于 2020 年 5 月进行了一项系统搜索,以查找评估 AN 治疗方法中 GI 症状的研究,这些研究在治疗前后都测量了 GI 症状(PROSPERO ID:CRD42020181328)。去除重复项后,筛选了 3370 项研究的标题和摘要。使用美国国立卫生研究院质量评估工具评估方法学质量。
经过全文筛选,符合纳入标准的 13 项研究(12 项观察性研究和 1 项随机双盲安慰剂对照试验)共纳入 401 名参与者。所有观察性研究均包含营养康复内容,其中一半(n=6)涉及同时进行心理治疗。随机对照试验报告了一种药物治疗方法。11 项研究报告称,在治疗后,所有(n=6)或至少一项(n=5)患者报告的 GI 症状都有所改善。两项研究报告没有变化。所有研究的方法学质量均为中等或较差。
这是第一项系统评价,旨在综合厌食症患者从开始治疗到结束治疗期间患者报告的 GI 症状的可用证据。结果表明,大多数研究表明,针对目前的治疗方法,一项或多项 GI 症状有所改善。未来的治疗方法应在其设计中考虑 GI 症状,以实现最佳的治疗依从性和结果。